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ABSTRACT
The immune epitope database analysis resource
(IEDB-AR: http://tools.iedb.org) is a collection of
tools for prediction and analysis of molecular
targets of T- and B-cell immune responses (i.e. epi-
topes). Since its last publication in the NAR
webserver issue in 2008, a new generation of
peptide:MHC binding and T-cell epitope predictive
tools have been added. As validated by different
labs and in the first international competition for
predicting peptide:MHC-I binding, their predictive
performances have improved considerably. In
addition, a new B-cell epitope prediction tool was
added, and the homology mapping tool was
updated to enable mapping of discontinuous
epitopes onto 3D structures. Furthermore, to serve
a wider range of users, the number of ways in which
IEDB-AR can be accessed has been expanded.
Specifically, the predictive tools can be program-
matically accessed using a web interface and can
also be downloaded as software packages.
INTRODUCTION
The immune system orchestrates various classes of mol-
ecules to detect an abnormal state of the host, as a ﬁrst
step toward the goal of protecting the host from diseases.
To achieve such detection, dedicated molecules such as
major histocompatibility complexes (MHCs), T-cell recep-
tors (TCRs) and B-cell receptors (BCRs) continuously
scan cellular surfaces and extra-intra-cellular spaces
for non-self molecules and trigger immune responses
upon their detection. Parts of such non-self molecules
(e.g. proteins, carbohydrates and other macromolecules)
recognized by the immune system are called epitopes.
Depending on the context of immune epitope recogni-
tion, different kinds of immune responses are initiated.
For instance, TCRs binding peptide:MHC-I (class I)
complexes presented on the cell surface are associated
with cytotoxic lymphocyte activity (i.e. cell killing);
whereas, TCRs binding peptide:MHC-II (class II) com-
plexes are associated with recruiting helper T-cells and
alerting B-cells. Thus, improved molecular-level under-
standing of immune epitope recognition will further
enhance the development of novel vaccines, diagnostics
and therapeutics in treating infectious and autoimmune
diseases, allergies and cancers.
To address this need, the immune epitope database-
analysis resource (IEDB-AR) aims to be the premier
resource in providing web-based tools for immune
epitope predictions and analyses. Since its publication in
the NAR webserver issue in 2008 (1), major updates and
the addition of new predictive tools have been made.
Speciﬁcally, six new peptide:MHC binding, one antigen
processing and one B-cell epitope predictive tool have
been added. In addition, binding afﬁnity data for
MHC-I and MHC-II molecules have been signiﬁcantly
expanded, resulting in both increased coverage of alleles
and improved accuracy for existing predictors.
THE WEB RESOURCE
Tools provided on the IEDB analysis resource website can
be grouped into those that make predictions or carry out
analyses (Table 1). Predictive tools can be further grouped
based on their targeted immune recognition contexts:
(i) peptide:MHC binding, (ii) antigen processing and
(iii) B-cell-receptor/antibody binding. Since the last
*To whom correspondence should be addressed. Tel: +1 858 752 6914; Fax: +1 858 752 6987; Email: bpeters@liai.org
Published online 18 May 2012 Nucleic Acids Research, 2012, Vol. 40, Web Server issue W525–W530
doi:10.1093/nar/gks438
 The Author(s) 2012. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
 at The Technical K
now
ledge Center of D
enm
ark on June 29, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
publication on the analysis resource, major updates and
additions have been made to tools in all categories. The
following sections describe these updates in detail.
All T-cell epitope predictive tools take protein se-
quences represented by single letter amino acids as
input. Once submitted, protein sequences are broken
into appropriate peptide lengths as speciﬁed by the user.
Predictions are made against the set of MHC molecules
chosen by the user. Outputs consist of a list of peptides
and their predicted scores, indicating their likelihood of
binding or being epitopes.
MHC class I peptide binding predictions
For peptide:MHC-I binding prediction, a number of im-
provements and additions have been made since the last
web-server issue on the IEDB-AR in 2008. Speciﬁcally,
larger datasets have been used to re-train all existing
prediction methods, adding multiple new MHC molecules
in the process. Currently binding afﬁnity data and corres-
ponding predictors are available for 56 human, 19
non-human primate and six mouse molecules. This repre-
sents an increase of 42% in the number of molecules
covered.
Furthermore, three powerful new prediction methods
have been added. The ﬁrst, SMMPMBEC (2) is an improve-
ment of the SMM scoring matrix-based predictor (3).
SMMPMBEC implements a Bayesian approach that
prefers scoring matrices that are consistent with known
amino acid similarities. This is particularly helpful when
estimating the contribution of speciﬁc residues to peptide
binding for molecules characterized by limited binding
data. The second newly added method, NetMHCpan
(4), is a neural-network based predictor, similar to
NetMHC (5), but with the crucial difference that for
NetMHCpan, a single network-ensemble is trained on
all MHC molecules simultaneously, incorporating both
the peptide and contact residues from the MHC se-
quences. This allows the method to extrapolate and
estimate binding predictions for any MHC molecule,
including those not included in the training set (6), by
leveraging known sequence:binding data afﬁnity relation-
ships and extending this to those MHC molecules with no
binding data.
Consensus is the third newly added method, which has
not been previously described. The method was motivated
by observations made by investigators in the machine-
learning community that combining predictions from
different predictors may yield higher predictive perform-
ance than any of the individual predictors (7). In the
current implementation, predictions from various pre-
dictors are ﬁrst transformed into percentile scores,
thereby allowing comparisons across predictors on a
uniform scale. For a given peptide and a predictor, a per-
centile score is deﬁned as a percentage of random peptides
sampled from naturally occurring proteins that score
better than the peptide. Using the consensus approach,
the ﬁnal predicted binding afﬁnity score for the peptide
is a median of percentile scores from the different pre-
dictors. Notable use of an early version of a consensus
method for a large-scale prediction has been described in
Moutaftsi et al. (8).
Benchmarks for the different tools have been performed
in the respective publications with average predictive per-
formances of 0.881 AUC for the class I (NetMHCpan-2.0
against HLA A and B molecules) (4). Of special note, an
MHC class I prediction competition was held recently for
the ﬁrst time (9). Tested on blind peptide:MHC binding
datasets generated by an independent group, the consen-
sus method hosted at the IEDB-AR has consistently
ranked high (i.e. within the top 5 entries out of 20 total)
among competitors. The blind datasets were generated for
three molecules, each involving 9- and 10-mers. The
combined dataset consisted of 1200 measurements with
20% composed of binders, and the average predictive per-
formance on this dataset for the IEDB consensus predic-
tion was 0.96 AUC, notably higher than our own
prediction performance estimates, only surpassed by the
NetMHCcons (10), NetMHC and NetMHCpan methods.
To date, top-performing methods have been entirely
sequence based, despite potential advantages of struc-
ture-based methods. It is, however, expected that as struc-
tural modeling techniques improve, predictive methods
based on 3D structures with comparable accuracy will
emerge (11, 12).
MHC class II peptide-binding predictions
Similar to the class I tools, all class II tools have been
re-trained using newly available binding data.
Importantly, a large set of data have become available
that covers a set of prevalent HLA-DP and DQ molecules,
for which previously there were very little data available.
This was not due to lack of importance of these molecules
but rather due to the signiﬁcantly greater experimental
effort involved in characterizing them when compared to
Table 1. An overview of immune-epitope related bioinformatics tools provided by the IEDB-AR
Tools category New or updated tools Descriptions
Prediction T-cell MHC-I Consensus, SMMPMBEC, NetMHCpan Predict peptides that bind to MHC class I molecules
MHC-II Consensus, NN-align, NetMHC-IIpan Predict peptides that bind to MHC class II molecules
Antigen
processing
NetCTLpan Predict epitopes by integrating proteasomal cleavage,
TAP efﬁciency, peptide:MHC-I binding scores
B-cell ElliPro Predict protein regions that are most likely to be bound
by antibodies
Epitope analysis Homology Mapping Map linear and discontinuous epitopes onto 3D structures
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the HLA DR molecules. With the new data available, for
the ﬁrst time, the prediction methods cover a large fraction
of human MHC class II molecules (13). The molecules
covered (Table 2) were selected for experimental charac-
terization based on their high frequency in the worldwide
human population.
Two new methods for class II binding prediction
[NN-align (8) and NetMHCIIpan (9)] were added to the
resource website. Both methods are artiﬁcial neural
network based and are trained using a concurrent align-
ment and weight optimization neural network training
procedure described in (14–16). NN-align is molecule-
speciﬁc (i.e. one neural network method is trained for
each MHC class II molecule), and NetMHCIIpan is
HLA-DR pan-speciﬁc (i.e. one neural network method is
trained covering all HLA-DR molecules). Both methods
include encoding of peptide ﬂanking regions (PFR), PFR
length and the peptide length to boost the predictive per-
formance. The pan speciﬁcity of NetMHCIIpan is
achieved (as was the case for NetMHCpan) by including
both the peptide and contact residues from the MHC se-
quences in the network training. Both novel methods have
demonstrated superior predictive performance compared
to the earlier methods included in the resource website
with average AUC performance values of 0.821
(NN-align) and 0.846 (NetMHCIIpan) when bench-
marked against a large set of HLA-DR molecules (15).
MHC class I antigen processing predictions
In addition to binding of peptides to MHC molecules,
there are additional steps in the MHC class I pathway
that a peptide has to pass in order to be recognized by
the immune system (17). This includes proteasomal
cleavage (18, 19) and TAP transport (20), which have
been utilized in combination with MHC binding predic-
tions to identify T-cell epitopes (21). A new such integra-
tive predictive approach has recently been developed
called NetCTLpan (22), distinguished by the use of the
NetMHCpan method for the peptide:MHC binding step.
It has been demonstrated that for cases where a low false
positive rate is desired, (high speciﬁcity predictions) pro-
teasome cleavage and transport efﬁciency by TAP contrib-
ute to improved predictive performances (22).
User interface updates for MHC class I/II peptide
binding tools
The web interfaces to the MHC class I and II binding
predictive tools have been updated based on user
feedback. One example was that the selection of MHC
molecules from a drop-down list used to make predictions
had become cumbersome, especially with the addition of
the NetMHCpan tools. To address this, there is now a
checkbox that is selected by default that limits the MHC
molecules included for selection to those that occur in at
least 1% of the human population. The vast majority of
users are focusing on such molecules, and the smaller list is
much easier to navigate, whereas the entirety of alleles is
still available by simply unselecting the checkbox. This
feature is currently available only for MHC class I tools.
In addition, the user can select different combinations
of MHC molecules and lengths, so that a different group
of predictions can be run in one iteration rather than re-
peatedly selecting prediction method and retrieving
results. Also with the addition of NetMHCpan, one can
upload any MHC molecule of interest to allow predictions
for MHC molecules outside of those provided by the
IEDB-AR. Once a table of predictions is generated, it
can be ‘expanded’ to show greater detail of how individual
components of the scores contribute to the ﬁnal scores
(Figure 1).
Finally, another user request was for the IEDB team to
spell out, which prediction method is recommended for a
given task. Therefore, a default choice is provided, named
‘IEDB Recommended’. Based on availability of predictors
and previously observed predictive performance, this se-
lection tries to use the best possible method for a given
MHC molecule. Currently, for peptide:MHC-I binding
prediction, for a given MHC molecule, ‘IEDB
Recommended’ uses the consensus method consisting of
NetMHC, SMM and CombLib if a trained predictor is
available for the molecule. Otherwise, NetMHCpan is
used. This choice was motivated by the expected predictive
performance of the methods in decreasing order:
Consensus>NetMHC> SMM>NetMHCpan>Comb-
Lib. For peptide:MHC-II binding prediction, ‘IEDB
Recommended’ again uses the ‘consensus’ approach,
combining NN-align, SMM-align and CombLib. The
expected predicted performance for MHC-II binding
methods in decreasing order are Consensus>
NetMHCIIpan>NN-align> SMM-align>CombLib. Of
note, we fully expect the IEDB recommendation to
Table 2. HLA-DP, DQ, DR molecules chosen based on their high
frequency in the human population. Allele frequency data are
provided by dbMHC
Allelic variant Allele frequency
HLA-DPA1*0201-DPB1*0101 16
HLA-DPA1*0103-DPB1*0201 17.5
HLA-DPA1*01-DPB1*0401 36.2
HLA-DPA1*0301-DPB1*0402 41.6
HLA-DPA1*0201-DPB1*0501 21.7
HLA-DQA1*0501-DQB1*0201 11.3
HLA-DQA1*0501-DQB1*0301 35.1
HLA-DQA1*0301-DQB1*0302 19
HLA-DQA1*0401-DQB1*0402 12.8
HLA-DQA1*0101-DQB1*0501 14.6
HLA-DQA1*0102-DQB1*0602 14.6
HLA-DRB1*0101 5.4
HLA-DRB1*0301 13.7
HLA-DRB1*0401 4.6
HLA-DRB1*0404 3.6
HLA-DRB1*0405 6.2
HLA-DRB1*0701 13.5
HLA-DRB1*0802 4.9
HLA-DRB1*0901 6.2
HLA-DRB1*1101 11.8
HLA-DRB1*1302 7.7
HLA-DRB1*1501 12.2
HLA-DRB3*0101 26.1
HLA-DRB4*0101 41.8
HLA-DRB5*0101 16
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change as we perform larger benchmarks of newly de-
veloped methods on blind datasets to determine an
accurate assessment of prediction quality. For example,
recent evaluations suggested that NetMHCpan is
actually superior in performance to all allele-speciﬁc pre-
dictors unless there is a very large amount of data avail-
able for the particular allele (10). If this result can be
conﬁrmed on new binding datasets, the IEDB recommen-
dation will change.
B-cell epitope prediction
A new addition to IEDB-AR since its last publication is
the ElliPro tool (23). ElliPro predicts linear and discon-
tinuous epitopes for a protein structure or sequence
provided by the user; for sequences, the structure is
modeled using MODELLER (24). ElliPro is based on
the geometrical properties of protein structure and does
not require training. Tested on a benchmark dataset of
discontinuous epitopes inferred from 3D structures of
antibody–protein complexes (25), ElliPro has an AUC
of 0.73 when the most signiﬁcant prediction was con-
sidered for each protein. Since the rank of the best predic-
tion was at most in the top three for >70% of proteins and
never exceeded ﬁve, ElliPro can be considered a useful
research tool for identifying antibody epitopes in protein
antigens. Details on the comparison of ElliPro with other
structure-based epitope prediction methods can be found
in (23). It would also be interesting to compare the method
against sequence-based approaches as well (26).
Epitope analysis: Homology mapping tool
The homology mapping tool enables analysis of an
epitope’s location in the 3D structure of its source
protein. For a given epitope, linear or discontinuous,
from IEDB or submitted by a user, the tool searches for
known 3D protein structures in the Protein Data Bank
(PDB) (27) that are homologous to the epitope source
sequence. The output page (Figure 2) provides mapping
of the epitope to the source sequence, the PDB hits that
contain the epitope regions, secondary structures and
solvent accessibilities for each residue, presented in the
format of either pairwise or multiple sequence alignment
for the selected PDB hits, obtained using ClustalW2
(28,29). Residues in the alignment are colored by relative
solvent accessibility; coloring can be modiﬁed according
to the user-speciﬁed cutoffs on relative solvent accessi-
bility of all atoms or side chain atoms only. PDB struc-
tures with mapped epitopes can be visualized using
EpitopeViewer (30). The 3D viewer feature uses java
webstart technology, which does not appear to be
smoothly integrated into Google chrome browsers. To
use the feature, we recommend using Firefox.
In addition to maintaining the homology mapping tool,
IEDB-AR is open to incorporating tools developed by
external groups. One such type of tools that is of much
interest would address the problem of choosing an optimal
set of epitopes given various constraints for vaccine design
(31,32).
IEDB application programming interface (IEDB-API) for
peptide:MHC binding predictive tools
A frequent user request has been to enable integration
of IEDB-AR tools into external applications. For
example, the Los Alamos HIV Immunology Database
(33) wanted to utilize the IEDB-AR MHC binding predic-
tion for their Epitope Location Finder tool (ELF: www
.hiv.lanl.gov/content/sequence/ELF/epitope_analyzer.
html). To address this general need, an application
programming interface (IEDB-API) for tools predictive
of MHC binding has been implemented.
IEDB-API has been implemented using a simple
(RESTful) interface that allows a user to send a prediction
request via a simple HTTP POST request to the IEDB-AR
Figure 1. Screenshot of the peptide:MHC-I binding predictive tool results page generated using the ‘IEDB recommended’ option. The ﬁrst high-
lighted area at the top indicates a checkbox with which the user can expand the table to display method-speciﬁc predictions. The second highlighted
area at the bottom allows the user to download the prediction results as a text ﬁle.
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server, which in turn generates a page with the prediction
results. Such programmatic calls can be integrated into
external applications, and they not only allow the user
to run prediction jobs in batch mode but also ensure
that the most up-to-date predictions will continue to be
used. Finally, these calls do not require any local installa-
tion. Details on the use of IEDB-API as well as examples
are provided at the IEDB-AR website (http://tools.iedb.
org/main/html/iedb_api.html).
SOFTWARE DISTRIBUTION PACKAGES OF
PREDICTIVE TOOLS
In addition to the web services described above, down-
loadable versions of the predictive tools are available
freely for educational use, and with a licensing fee for
commercial use. The MHC class I and class II binding
prediction tools are available as a standalone package in
compressed tarball and Ubuntu packages. These packages
consist of Python scripts that are directly callable from the
command line, making it convenient for batch processing.
Additionally, a virtual machine image of the IEDB
Tools server is available for download and includes all
tools on the website, with the user-friendly web interface
to which users are accustomed. The image can be easily
imported into an existing VMware ESX/ESXi deployment
for site-wide access and should also run on a local
installation of any virtualization software that supports
OVF format. Both versions are updated on a 6-month
cycle with the release of the website.
SUMMARY
A comprehensive set of immune epitope prediction and
analysis tools are provided in the IEDB-AR. All compo-
nents of the resource have been updated since the last
publication in 2008, including retraining of prediction
methods and addition of new methods. Furthermore,
with the ability to use the IEDB-AR tools through a
web-based API, it is becoming easier to integrate the
tools into external applications. In the future, we plan to
continue to make improvements to existing tools and add
new ones. In addition to these efforts, we very much en-
courage people to notify us of predictive tools they are
willing to contribute to the IEDB.
FUNDING
The IEDB is funded by National Institutes of Health
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Figure 2. Screenshots of the homology modeling tool. (A) The input page. (B) The output page: a pair-wise sequence alignment of the source protein
and one of the PDB hits. Epitope residues are shown in orange. Solvent exposed residues (with a relative solvent accessibility of side chain atoms,
RSA, above 40%) are shown in red and buried (RSA below 7%), in blue (these cut-offs can be changed as shown in C). In the annotation for
secondary structures (34), ‘H’ denotes an alpha-helix; ‘G’, a 3-10 helix; ‘E’, a beta-strand; ‘T’, a turn; ‘X’, no structure. (C) The output page: a
fragment of a multiple sequence alignment of the source protein and all PDB hits (at the Blast E-value< 1.0E-3). (D) Default view of the protein
source and epitope (colored in blue) in EpitopeViewer. The view can be changed using the EpitopeViewer’s tools and shortcuts accessible on the right
top panel.
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